Infliximab vs Adalimumab: Which Is Best for Behçet Syndrome? ...Middle East

Medscape - News
Both infliximab and adalimumab were found to be effective in achieving remission and enhancing quality of life while having a high level of tolerability in patients with mucocutaneous Behçet syndrome. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Infliximab vs Adalimumab: Which Is Best for Behçet Syndrome? )

Also on site :



Latest News